The bill will allow terminally ill patients to request experimental drugs that the FDA has not yet approved.
When used as a pain reliever, methadone is especially likely to cause unintentional overdoses.
The outlined agreement emphasizes collaboration on common interests to improve food safety and to provide more information to Americans on products they purchase from store shelves.
Homeopathic products include everything from the radically alternative to certain over-the-counter cold and allergy medicines.
The new treatment may help overcome some courts' lingering—and dangerous—aversion to medication-assisted treatment.
Buprenorphine has long been considered a gold-standard treatment for addiction to prescription painkillers or heroin.
Under the new rules, a recent procedure at a Florida clinic that left three elderly women blind would have been outlawed from the start.
The study looked at recently approved major changes to critical devices such as blood-sugar monitors, stents, and defibrillators meant to restart the heart.
The FDA is taking a side in a hot debate in public health right now over what to do about new tobacco products.
A meta-study finds "female Viagra" to have low-to-moderate benefits and side effects.
University of California–San Francisco researcher Cristin Kearns dropped a promising career at the Kaiser Foundation to dig through sugar industry archives for a smoking gun. With help from the man who brought down Big Tobacco, she’s now proving that Big Sugar steered scientists away from looking at the ingredient’s harmful effects.
Placed in historical perspective, the popular opposition to things like GMOs and vaccines, much like 19th-century opposition to fertilizers and insecticides, reflects less an overt rejection of science than a distrust of experts who peddle it.
The hidden pipeline for America’s mystery meat may start at home.
Too often, doctors aren't using sound science when they prescribe a drug for unapproved uses, a new study finds.
A bill that would speed up approval for medications and medical devices shows how a major initiative can get traction even in the midst of Washington gridlock—but critics say all the lobbying is drowning out some warnings about patient safety.